Observations placeholder
Truvada
Identifier
015762
Type of Spiritual Experience
Number of hallucinations: 53
Background
A description of the experience
Tenofovir/emtricitabine, trademark Truvada by Gilead Sciences, is a fixed-dose combination of two antiretroviral drugs used for the treatment of HIV. It consists of 300 milligrams of tenofovir disoproxil fumarate (of which 245 mg tenofovir) and 200 milligrams of emtricitabine.
The drug has been approved for pre-exposure prophylaxis against HIV infection. The Food and Drug Administration approved it for prophylactic use on July 16, 2012.
On Dec, 21, 2016 16,713 people reported to have side effects when taking Truvada.
Among them, 223 people (1.33%) have Death
Time on Truvada when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 28.57% | 28.57% | 12.24% | 26.53% | 4.08% | 0.00% | 0.00% |
On Dec, 23, 2016 16,713 people reported to have side effects when taking Truvada.
Among them, 53 people (0.32%) have Hallucination
Time on Truvada when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 0.00% | 75.00% | 0.00% | 25.00% | 0.00% | 0.00% | 0.00% |